Comparative techno-economic assessment of multi-feedstock to multi-product integrated lignocellulosic biorefinery

IF 3.7 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Georgeio Semaan , Abdullah Bilal Öztürk , Gopalakrishnan Kumar
{"title":"Comparative techno-economic assessment of multi-feedstock to multi-product integrated lignocellulosic biorefinery","authors":"Georgeio Semaan ,&nbsp;Abdullah Bilal Öztürk ,&nbsp;Gopalakrishnan Kumar","doi":"10.1016/j.bej.2025.109892","DOIUrl":null,"url":null,"abstract":"<div><div>A techno‑economic assessment was performed for a multi‑feedstock lignocellulosic biorefinery that converts Norwegian tomato and cucumber crop residues, spent coffee grounds, and brewers’ spent grain into value‑added chemicals. Scenario 1 integrates dilute oxalic‑acid hydrolysis (DAH) with oxalic‑acid‑assisted ethanol‑organosolv delignification (ORG) and co‑produces ethanol, lactic acid, ethanol‑organosolv lignin, furfural, 5‑hydroxymethylfurfural, and electricity. Scenario 2 omits the lactic‑acid train, whereas Scenario 3 employs DAH, only without the ORG or lactic acid sections. Mass and energy balance simulations informed discounted cash flow models for feedstock capacities of 25 and 250 kt/yr. At 25 kt/yr, all scenarios were unprofitable. Scaling to 250 kt/yr improved outcomes for Scenarios 1 and 3, yielding 11.5–12.6 % internal rate of return (IRR), US$ 183.7–185MM net present value (NPV). ORG inclusion reduced overall returns due to elevated capital and operating costs. Integrated operation produced negative net unit production costs, indicating internal cost cross-subsidization among co-products. Sensitivity analysis identified revenue and operating expenditures as primary determinants of NPV and IRR. Monte Carlo analysis estimated a 93.7 % probability of profitability in all simulated outcomes. The findings underscore the importance of scaling up and diversifying product portfolio in future biorefinery deployments.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"224 ","pages":"Article 109892"},"PeriodicalIF":3.7000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25002669","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

A techno‑economic assessment was performed for a multi‑feedstock lignocellulosic biorefinery that converts Norwegian tomato and cucumber crop residues, spent coffee grounds, and brewers’ spent grain into value‑added chemicals. Scenario 1 integrates dilute oxalic‑acid hydrolysis (DAH) with oxalic‑acid‑assisted ethanol‑organosolv delignification (ORG) and co‑produces ethanol, lactic acid, ethanol‑organosolv lignin, furfural, 5‑hydroxymethylfurfural, and electricity. Scenario 2 omits the lactic‑acid train, whereas Scenario 3 employs DAH, only without the ORG or lactic acid sections. Mass and energy balance simulations informed discounted cash flow models for feedstock capacities of 25 and 250 kt/yr. At 25 kt/yr, all scenarios were unprofitable. Scaling to 250 kt/yr improved outcomes for Scenarios 1 and 3, yielding 11.5–12.6 % internal rate of return (IRR), US$ 183.7–185MM net present value (NPV). ORG inclusion reduced overall returns due to elevated capital and operating costs. Integrated operation produced negative net unit production costs, indicating internal cost cross-subsidization among co-products. Sensitivity analysis identified revenue and operating expenditures as primary determinants of NPV and IRR. Monte Carlo analysis estimated a 93.7 % probability of profitability in all simulated outcomes. The findings underscore the importance of scaling up and diversifying product portfolio in future biorefinery deployments.
多原料与多产品一体化木质纤维素生物炼制的技术经济比较评价
对多原料木质纤维素生物精炼厂进行了技术经济评估,该精炼厂将挪威番茄和黄瓜作物残茬、废咖啡渣和酿酒师的废谷物转化为增值化学品。方案1将稀草酸水解(DAH)与草酸辅助乙醇-有机溶剂脱木质素(ORG)相结合,共同生产乙醇、乳酸、乙醇-有机溶剂木质素、糠醛、5 -羟甲基糠醛和电。方案2省略了乳酸列车,而方案3采用DAH,仅没有ORG或乳酸部分。质量和能量平衡模拟为25和250 kt/年的原料能力提供了贴现现金流模型。在25 kt/yr时,所有情况都无利可图。如果规模扩大到250 kt/年,情景1和情景3的结果将得到改善,内部收益率(IRR)为11.5 - 12.6% %,净现值(NPV)为183.7-185MM美元。由于资本和运营成本的增加,ORG的加入降低了总体回报。综合经营产生负的单位净生产成本,表明副产品之间存在内部成本交叉补贴。敏感性分析确定收入和营业支出是NPV和IRR的主要决定因素。蒙特卡罗分析估计在所有模拟结果中盈利的概率为93.7 %。研究结果强调了在未来生物炼制部署中扩大和多样化产品组合的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biochemical Engineering Journal
Biochemical Engineering Journal 工程技术-工程:化工
CiteScore
7.10
自引率
5.10%
发文量
380
审稿时长
34 days
期刊介绍: The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology. The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields: Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells Bioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信